Ossiam’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1M | Sell |
36,294
-77,201
| -68% | -$26.4M | 0.17% | 91 |
|
|
2026
Q1 | $39.9M | Buy |
113,495
+98,441
| +654% | +$35.1M | 0.7% | 25 |
|
|
2025
Q4 | $4.93M | Buy |
15,054
+5,024
| +50% | +$1.59M | 0.1% | 102 |
|
|
2025
Q3 | $2.83M | Sell |
10,030
-43
| -0.4% | -$12.5K | 0.04% | 276 |
|
|
2025
Q2 | $2.81M | Sell |
10,073
-13,818
| -58% | -$3.91M | 0.03% | 228 |
|
|
2025
Q1 | $7.44M | Buy |
23,891
+11,661
| +95% | +$3.44M | 0.1% | 116 |
|
|
2024
Q4 | $3.19M | Sell |
12,230
-501
| -4% | -$149K | 0.06% | 186 |
|
|
2024
Q3 | $4.1M | Sell |
12,731
-192,941
| -94% | -$63.1M | 0.08% | 122 |
|
|
2024
Q2 | $64.3M | Buy |
205,672
+156,258
| +316% | +$45.9M | 1.22% | 21 |
|
|
2024
Q1 | $14M | Buy |
49,414
+29,975
| +154% | +$8.77M | 0.25% | 71 |
|
|
2023
Q4 | $5.6M | Sell |
19,439
-228,853
| -92% | -$62.4M | 0.09% | 110 |
|
|
2023
Q3 | $66.7M | Buy |
248,292
+19,901
| +9% | +$4.97M | 1.18% | 19 |
|
|
2023
Q2 | $50.7M | Buy |
228,391
+184,926
| +425% | +$42.9M | 0.91% | 30 |
|
|
2023
Q1 | $10.5M | Sell |
43,465
-13,047
| -23% | -$3.2M | 0.22% | 82 |
|
|
2022
Q4 | $14.8M | Buy |
56,512
+30,266
| +115% | +$8.11M | 0.38% | 63 |
|
|
2022
Q3 | $5.92M | Sell |
26,246
-68,565
| -72% | -$16.6M | 0.17% | 102 |
|
|
2022
Q2 | $23.1M | Buy |
94,811
+17,967
| +23% | +$4.4M | 0.69% | 39 |
|
|
2022
Q1 | $18.6M | Buy |
76,844
+64,825
| +539% | +$14.9M | 0.49% | 47 |
|
|
2021
Q4 | $2.7M | Buy |
12,019
+6,250
| +108% | +$1.32M | 0.07% | 162 |
|
|
2021
Q3 | $1.23M | Sell |
5,769
-46,398
| -89% | -$10.7M | 0.03% | 221 |
|
|
2021
Q2 | $12.6M | Buy |
52,167
+25,788
| +98% | +$6.34M | 0.34% | 57 |
|
|
2021
Q1 | $6.56M | Buy |
26,379
+26,031
| +7,480% | +$6.21M | 0.2% | 81 |
|
|
2020
Q4 | $80K | Sell |
348
-6,942
| -95% | -$1.6M | ﹤0.01% | 367 |
|
|
2020
Q3 | $1.85M | Sell |
7,290
-23,842
| -77% | -$5.91M | 0.08% | 147 |
|
|
2020
Q2 | $7.34M | Sell |
31,132
-30,910
| -50% | -$7.05M | 0.47% | 43 |
|
|
2020
Q1 | $12.6M | Sell |
62,042
-68,803
| -53% | -$15M | 0.86% | 31 |
|
|
2019
Q4 | $31.5M | Buy |
130,845
+130,396
| +29,041% | +$28.7M | 2.41% | 9 |
|
|
2019
Q3 | $87K | Sell |
449
-34
| -7% | -$6.53K | 0.01% | 383 |
|
|
2019
Q2 | $89K | Buy |
+483
| New | +$86.5K | 0.01% | 382 |
|
|
2019
Q1 | – | Sell |
-2,478
| Closed | -$482K | – | 278 |
|
|
2018
Q4 | $482K | Buy |
+2,478
| New | +$483K | 0.07% | 142 |
|
Other funds holding AMGN
Ossiam's AMGN Position: Q2 2026 in Review
Ossiam reduced its Amgen (AMGN) stake by 68% in Q2 2026, selling an estimated $26.4M and leaving 36,294 shares worth $13.1M. The position accounts for 0.17% of the portfolio, ranked #91.
Ossiam first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $66.7M in Q3 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Ossiam held 36,294 shares of Amgen worth $13.1M as of Q2 2026.
- Ossiam sold 77,201 Amgen shares in Q2 2026, an estimated $26.4M.
- Amgen made up 0.17% of Ossiam's portfolio in Q2 2026, its #91 holding.
- Ossiam first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
- Ossiam's Amgen position peaked at $66.7M in Q3 2023.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.